Perrigo Says FDA Approved Its Oral Contraceptive Pill for OTC Use
13 Julio 2023 - 8:25AM
Noticias Dow Jones
By Will Feuer
Healthcare product and pharmaceuticals manufacturer Perrigo said
the U.S. Food and Drug Administration has approved the company's
oral contraceptive Opill for over-the-counter use in all ages.
Opill will be the first-ever birth control pill available
over-the-counter without needing a doctor's prescription in the
U.S. The oral contraceptive will be sold in stores and online at
leading retailers across the U.S. early in the first quarter of
2024, Perrigo said.
Shares rose 5.8% to $35.00 in premarket trading Thursday.
Write to Will Feuer at Will.Feuer@wsj.com
(END) Dow Jones Newswires
July 13, 2023 09:10 ET (13:10 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Perrigo Company Plc Irel... (NYSE:PRGO)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Perrigo Company Plc Irel... (NYSE:PRGO)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
